✦ LIBER ✦

TWO-YEAR SUSTAINED EFFICACY OF A NOVEL, POLYMER-FREE SIROLIMUS ELUTING STENT: LATE RESULTS OF THE VESTASYNC II TRIAL

✍ Scribed by José de Ribamar Costa; Alexandre Abizaid; Ricardo Costa; Breno Almeida; Fausto Feres; Marco Perin; Luiz Fernando Tanajura; Luiz Fernando Tanajura; Amanda Sousa; J Eduardo Sousa

Book ID: 118582025
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 105 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60213-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-448: Two-year Results of the Vestasy

TCT-448: Two-year Results of the Vestasync I trial with a novel, third-generation, hydroxyapatite polymer-free sirolimus-eluting stent

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 188 KB

VERY LONG-TERM RESULTS (> 2 YEAR) OF THE

VERY LONG-TERM RESULTS (> 2 YEAR) OF THE VESTASYNC I TRIAL WITH A NOVEL, THIRD-GENERATION, HYDROXYAPATITE POLYMER-FREE SIROLIMUS-ELUTING STENT

✍ de Ribamar Costa, Jose; Abizaid, Alexandre; Costa, Ricardo; Feres, Fausto; Abiza 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 132 KB

TCT-653 Assessment of endothelial functi

TCT-653 Assessment of endothelial function in patients randomly treated with a polymer-free sirolimus eluting stent and its bare-metal equivalent: results of the VESTASYNC II trial

✍ Breno Almeida; Jose Costa Jr; Ricardo Costa; Alexandre Abizaid; Mirela Lima; Mar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Five-year clinical outcomes of a polymer

Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: Final results of the intracoronary stenting and angiographic restenosis – test equivalence between two drug-eluting stents (ISAR-TEST) trial

✍ Lamin King; Robert A. Byrne; Julinda Mehilli; Albert Schömig; Adnan Kastrati; Ju 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 828 KB

Sustained clinical safety and efficacy o

Sustained clinical safety and efficacy of a biodegradable-polymer coated sirolimus-eluting stent in “real-world” practice: Three-year outcomes of the CREATE (multi-center registry of EXCEL biodegradable polymer drug eluting stents) study

✍ Yaling Han; Quanmin Jing; Yi Li; Lixia Yang; Huiliang Liu; Xiaoming Shang; Tiemi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Randomized evaluation of two drug-elutin

Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-Year results of the PAINT trial

✍ Pedro A. Lemos; Bruno Moulin; Marco A. Perin; Ludmilla A.R.R. Oliveira; J. Airto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

## Abstract Objectives: We tested two novel drug‐eluting stents (DES), covered with a biodegradable‐polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). The DES differed by the drug, but were identical otherwise, allowing to comp